Champions Oncology, Inc. SEC filings CSBR
Champions Oncology, Inc. has 655 filings in SEC EDGAR's recent list, going back to Sep 13, 1995. Its latest annual report, Form 10-K, was filed on Jul 27, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 11, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (shareholder vote results). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Aug 28, 2026 | — |
| DEF 14A | Proxy statement | Aug 28, 2026 | Aug 27, 2026 |
| DEFA14A | Additional proxy material | Aug 22, 2025 | — |
| DEF 14A | Proxy statement | Aug 22, 2025 | Aug 22, 2025 |
| DEFA14A | Additional proxy material | Aug 27, 2024 | — |
| DEF 14A | Proxy statement | Aug 27, 2024 | Aug 27, 2024 |
| DEFA14A | Additional proxy material | Aug 28, 2023 | — |
| DEF 14A | Proxy statement | Aug 28, 2023 | Aug 28, 2023 |
| DEF 14A | Proxy statement | Aug 31, 2022 | Aug 29, 2022 |
| DEF 14A | Proxy statement | Aug 29, 2022 | Aug 29, 2022 |
| DEFA14A | Additional proxy material | Sep 1, 2021 | — |
| DEF 14A | Proxy statement | Aug 30, 2021 | Aug 30, 2021 |
| DEFA14A | Additional proxy material | Sep 11, 2020 | — |
| DEFM14A | Filing | Sep 11, 2020 | — |
| DEF 14A | Proxy statement | Aug 28, 2020 | Apr 30, 2020 |
| DEF 14A | Proxy statement | Aug 28, 2019 | Apr 30, 2019 |
| DEF 14A | Proxy statement | Aug 28, 2018 | Apr 30, 2018 |
| DEF 14A | Proxy statement | Aug 28, 2017 | Apr 30, 2017 |
| DEF 14A | Proxy statement | Aug 25, 2016 | Oct 13, 2016 |
| DEFA14A | Additional proxy material | Aug 31, 2015 | — |
| DEF 14A | Proxy statement | Aug 28, 2015 | Oct 13, 2015 |
| DEF 14C | Information statement | Mar 30, 2015 | Mar 27, 2015 |
| PRE 14C | Form pre 14c | Mar 16, 2015 | Mar 13, 2015 |
| DEFA14A | Additional proxy material | Aug 29, 2014 | — |
| DEF 14A | Proxy statement | Aug 28, 2014 | Oct 13, 2014 |
| DEF 14A | Proxy statement | Aug 27, 2013 | Oct 15, 2013 |
| PRE 14A | Preliminary proxy statement | Aug 16, 2013 | Aug 16, 2013 |
| DEF 14C | Information statement | Mar 7, 2011 | Mar 7, 2011 |
| PRE 14C | Preliminary information statement | Feb 23, 2011 | Feb 18, 2011 |
| DEF 14A | Proxy statement | Nov 15, 1996 | Apr 30, 1996 |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CSBR (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 771856
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC. (until Mar 30, 2011); CHAMPIONS SPORTS INC (until Feb 16, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.